- With 3 COVID Vaccines Approved, Is There a ‘Best’ Shot?
- It’s Too Soon to Lift COVID Restrictions: Fauci
- Health Highlights: March 5, 2021
- AHA News: Why Did Yankees Manager Get a Pacemaker, and How Does It Work?
- When Facebook, Twitter Flag Posts as ‘Unverified,’ Readers Listen
- Lockdowns Tied to Temporary Drops in Illicit Drug Seizures
- Formaldehyde in Hair Straighteners Prompts FDA Warning
- Big Paychecks Pay Off in Self-Confidence, Study Finds
- Opioid Use (and Overuse) for Knee Arthritis Takes Big Financial Toll
- A Vaccine Against UTIs? New Mouse Study Brings Shot Closer
Clinical Trials Update: Feb. 4, 2010
Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Hepatitis B Virus (HBV)
If you are aged 40 to 70 and have never been vaccinated for HBV, you may be eligible to participate in this study of an investigational vaccine.
The research site is in Chicago, Ill.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/Hepatitis.aspx.
—–
Rheumatoid Arthritis
If your rheumatoid arthritis symptoms persist despite treatment, you may qualify for this study of an investigational drug.
The research site is in Bingham Farms, Mich.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/arthritis.aspx.
—–
Overweight Volunteers (Males 18-60)
This study is looking for overweight males, aged 18 to 60. The study involves one screening visit, one in-house stay of 35 nights, and one telephone follow-up. If you complete the study, you may receive up to $7,000 for time and travel.
The research site is in Baltimore, Md.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/weight_loss.aspx.
—–
Copyright 2010 ClinicalConnection.com. All rights reserved.
Source: HealthDay
